GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Happident (XSAT:OS BTA 2) » Definitions » Research & Development

Happident (XSAT:OS BTA 2) Research & Development : kr0.0 Mil (TTM As of Mar. 2018)


View and export this data going back to . Start your Free Trial

What is Happident Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Happident's Research & Development for the three months ended in Mar. 2018 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2018 was kr0.0 Mil.

Happident Research & Development Historical Data

The historical data trend for Happident's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Happident Research & Development Chart

Happident Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Happident Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Happident Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Happident  (XSAT:OS BTA 2) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Happident Research & Development Related Terms

Thank you for viewing the detailed overview of Happident's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Happident Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Happident (XSAT:OS BTA 2) » Definitions » Research & Development
Comparable Companies
TSXV:NXG WAR:DAM OSTO:FEEL MIL:HI ASX:ONT TSXV:META ATH:IATR ROCO:6665 HIIQ HQDA OSTO:MCOV B BSP:QUAL3 MGLN XPAR:GDS BSP:ODPV3 BSP:GNDI3 MOH WCG CNC HUM
Traded in Other Exchanges
N/A
Address
Danderydsgatan 26, Stockholm, SWE, 114 26
Website
https://www.happident.se
OraSolv AB is engaged in dental care business. Its activities include the acquisition, development and processing of companies and clinics active within the dental care industry.

Happident Headlines

No Headlines